STOCKHOLDERS EQUITY

3 Months Ended

Mar. 31, 2022

STOCKHOLDERS EQUITY

NOTE 17 - STOCKHOLDERS' EQUITY

NOTE 17 – STOCKHOLDERS’ EQUITY

Authorized Stock

The Company has authorized to issue is 150,000,000 common shares with a par value of $0.001 per share.

As of March 31, 2022 and March 31, 2021, there were 69,866,900 and 59,926,409 shares of the Company’s common stock issued and outstanding, respectively.

Common Share Issuances

From January 1, 2021 to March 31, 2021, the Company issued 157,693 common stock shares, at prices per share ranging from $1.04 to $1.03 in connection to issuances from our 2017 Equity Plan. The total value of these issuances was $0.02 million.

From January 1, 2021 to March 31, 2021, the Company issued 265,512 common stock shares, at prices per share ranging from $1.04 to $1.03 in connection to several consulting agreements. The total value of these issuances was $0.5 million.

From January 1, 2021 to March 31, 2021, the Company issued 26,936 common stock shares, at a price of $1.30 per share, from a cash-less exercise of certain warrants. Total value of these issuances was $0.03 million.

From January 1, 2022 to March 31, 2022, the Company issued 1,192,369 common stock shares, at a price per share of $0.19, the Alternative Conversion Price, in connection to conversion of $0.2 million of the Series B Note plus 472,631 common stock shares at a price per share of $0.19, in connection to the make-whole-amounts totaling $0.2 million per the terms of the Series B Note.

Common Stock Issuable

In 2018, the Company entered into an amendment to extend the maturity date of a convertible promissory note. As compensation for extending the note, the Company is to issue 150,000 common stock shares of the Company at a price of $2.05 per share. As of the filing of this Current Report on Form 10-Q, the Company has not yet issued these common stock shares and has recorded a stock issuable of $0.3 million.

From January 1, 2021 to March 31, 2021, the Company entered into Consulting Agreements (“Agreements”) with individuals. Per the terms of the Agreements, the Company is to issue 102,104 common stock shares of the Company at prices ranging from $1.72 to $1.85 per share. These common stock shares were issued subsequent to the filing of the Current Report on Form 10-Q filed on May 17, 2021.

On October 1, 2021, the Company entered into a Consulting Agreement (“Agreement”) with individuals. Per the terms of the Agreement, the Company is to issue 115,000 common stock shares of the Company at prices ranging from $0.30 to $0.68 per share. As of our filing of our Form 10-Q for the three months ended March 31, 2022, the Company has not yet issued these common stock shares and has recorded a stock payable of $0.05 million.